Ye Bi

690 total citations
9 papers, 534 citations indexed

About

Ye Bi is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Ye Bi has authored 9 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Biomedical Engineering. Recurrent topics in Ye Bi's work include Nanoparticle-Based Drug Delivery (3 papers), RNA Interference and Gene Delivery (3 papers) and 3D Printing in Biomedical Research (3 papers). Ye Bi is often cited by papers focused on Nanoparticle-Based Drug Delivery (3 papers), RNA Interference and Gene Delivery (3 papers) and 3D Printing in Biomedical Research (3 papers). Ye Bi collaborates with scholars based in United States and China. Ye Bi's co-authors include Ryan C. Fields, S. Peter Goedegebuure, Venktesh S. Shirure, Steven C. George, Matthew B. Curtis, Andrew Lezia, Rebecca Aft, Madeleine M. Goedegebuure, Fei Hao and Robert J. Lee and has published in prestigious journals such as Journal of Clinical Oncology, Advanced Drug Delivery Reviews and Scientific Reports.

In The Last Decade

Ye Bi

9 papers receiving 528 citations

Peers

Countries citing papers authored by Ye Bi

Since Specialization

Citations

This map shows the geographic impact of Ye Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Bi more than expected).

Fields of papers citing papers by Ye Bi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Bi. The network helps show where Ye Bi may publish in the future.

Co-authorship network of co-authors of Ye Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Bi. A scholar is included among the top collaborators of Ye Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Bi. Ye Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

#	Work	Indexed citations
1	sc2MeNetDrug: A computational tool to uncover inter-cell signaling targets and identify relevant drugs based on single cell RNA-seq data 2024 ·PLoS Computational Biology ·(unknown), S. Peter Goedegebuure, (unknown), Ye Bi, Ting Wang, Philip Payne, Li Ding, David G. DeNardo, William G. Hawkins, Ryan C. Fields, Fuhai Li	3
2	Treatment resistance to melanoma therapeutics on a single cell level 2024 ·Scientific Reports ·Lijun Yao, Bradley A. Krasnick, Ye Bi, Sunantha Sethuraman, S. Peter Goedegebuure, Amila Weerasinghe, Chris Wetzel, Qingsong Gao, (unknown), Jacqueline L. Mudd, Matthew A. Wyczalkowski, Michael C. Wendl, Li Ding, Ryan C. Fields	1
3	Tumor-on-chip modeling of organ-specific cancer and metastasis 2021 ·Advanced Drug Delivery Reviews ·Nuala Del Piccolo, Venktesh S. Shirure, Ye Bi, S. Peter Goedegebuure, Sepideh Gholami, Christopher C.W. Hughes, Ryan C. Fields, Steven C. George	91
4	Tumor-on-a-chip platform to interrogate the role of macrophages in tumor progression 2020 ·Integrative Biology ·Ye Bi, Venktesh S. Shirure, Ruiyang Liu, (unknown), Li Ding, J. Mark Meacham, S. Peter Goedegebuure, Steven C. George, Ryan C. Fields	55
5	Precision delivery of RAS-inhibiting siRNA to KRAS driven cancer via peptide-based nanoparticles 2019 ·Oncotarget ·Matthew S. Strand, Bradley A. Krasnick, Hua Pan, Xiuli Zhang, Ye Bi, (unknown), (unknown), Narendra V. Sankpal, Timothy P. Fleming, S. Peter Goedegebuure, David G. DeNardo, William E. Gillanders, William G. Hawkins, Samuel A. Wickline, Ryan C. Fields	60
6	IL23 and TGF-ß diminish macrophage associated metastasis in pancreatic carcinoma 2018 ·Scientific Reports ·(unknown), (unknown), Bradley A. Krasnick, Gustavo A. Miranda‐Carboni, Ryan C. Fields, Ye Bi, Abul Elahi, Abidemi Ajidahun, Paxton V. Dickson, Jeremiah L. Deneve, William G. Hawkins, David Shibata, Evan S. Glazer	18
7	Tumor-on-a-chip platform to investigate progression and drug sensitivity in cell lines and patient-derived organoids 2018 ·Lab on a Chip ·Venktesh S. Shirure, Ye Bi, Matthew B. Curtis, Andrew Lezia, Madeleine M. Goedegebuure, S. Peter Goedegebuure, Rebecca Aft, Ryan C. Fields, Steven C. George	236
8	Anti-KRAS siRNA nanoparticles for targeted colorectal cancer therapy. 2017 ·Journal of Clinical Oncology ·Bradley A. Krasnick, Matthew S. Strand, Ye Bi, Peter S. Goedegebuure, Timothy P. Fleming, Samuel A. Wickline, Hua Pan, Ryan C. Fields	1
9	Actively Targeted Nanoparticles for Drug Delivery to Tumor 2016 ·Current Drug Metabolism ·Ye Bi, Fei Hao, (unknown), Lesheng Teng, Robert J. Lee, Jing Xie	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact